Schonfeld Strategic Advisors LLC Entrada Therapeutics, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $14.6 Billion
- Q2 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Entrada Therapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 81,411 shares of TRDA stock, worth $1.39 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
81,411
Previous 28,951
181.2%
Holding current value
$1.39 Million
Previous $410,000
182.93%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TRDA
# of Institutions
85Shares Held
27.7MCall Options Held
100Put Options Held
0-
Baker Bros. Advisors LP New York, NY4.87MShares$83.3 Million0.92% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.43MShares$75.8 Million34.63% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA4.41MShares$75.5 Million29.39% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.13MShares$53.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$29 Million0.0% of portfolio
About Entrada Therapeutics, Inc.
- Ticker TRDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,368,500
- Market Cap $537M
- Description
- Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in precli...